Terns Pharmaceuticals Future Growth
Future criteria checks 2/6
Terns Pharmaceuticals's earnings are forecast to decline at 5.8% per annum while its annual revenue is expected to grow at 51.2% per year. EPS is expected to grow by 3.6% per annum. Return on equity is forecast to be -40.8% in 3 years.
Key information
-5.8%
Earnings growth rate
3.6%
EPS growth rate
| Pharmaceuticals earnings growth | 23.6% |
| Revenue growth rate | 51.2% |
| Future return on equity | -40.8% |
| Analyst coverage | Good |
| Last updated | 21 Aug 2024 |
Recent future growth updates
Recent updates
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth
Aug 18
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
May 03Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
Jan 12We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely
Sep 29Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Jun 06Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Feb 21Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Oct 03Terns Pharmaceuticals: The Easy Money Has Been Made
Sep 20Terns Pharmaceuticals GAAP EPS of -$0.55 beats by $0.08
Aug 08Is Terns Pharmaceuticals (NASDAQ:TERN) In A Good Position To Deliver On Growth Plans?
Jun 14Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Mar 16We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate
Nov 24We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely
Aug 24Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study
Jun 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3 | -137 | -109 | -136 | 5 |
| 12/31/2025 | 2 | -120 | -94 | -106 | 7 |
| 12/31/2024 | N/A | -99 | -93 | -86 | 7 |
| 6/30/2024 | N/A | -96 | -79 | -79 | N/A |
| 3/31/2024 | N/A | -91 | -76 | -76 | N/A |
| 12/31/2023 | N/A | -90 | -67 | -67 | N/A |
| 9/30/2023 | N/A | -85 | -59 | -59 | N/A |
| 6/30/2023 | N/A | -72 | -52 | -52 | N/A |
| 3/31/2023 | N/A | -68 | -50 | -50 | N/A |
| 12/31/2022 | N/A | -60 | -49 | -49 | N/A |
| 9/30/2022 | 1 | -59 | -49 | -49 | N/A |
| 6/30/2022 | 1 | -54 | -44 | -43 | N/A |
| 3/31/2022 | 1 | -51 | -41 | -41 | N/A |
| 12/31/2021 | 1 | -50 | -42 | -42 | N/A |
| 9/30/2021 | N/A | -35 | -39 | -39 | N/A |
| 6/30/2021 | N/A | -35 | -37 | -37 | N/A |
| 3/31/2021 | N/A | -34 | -37 | -37 | N/A |
| 12/31/2020 | N/A | -29 | -30 | -30 | N/A |
| 9/30/2020 | N/A | -40 | -33 | -32 | N/A |
| 12/31/2019 | N/A | -69 | -67 | -66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TERN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TERN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TERN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TERN's revenue (51.2% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: TERN's revenue (51.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TERN is forecast to be unprofitable in 3 years.